National Comprehensive Cancer Network

NCCN Academy for Excellence and Leadership in Oncology™
Interactive CME
NCCN Oncology Case Management Program™

Educational Events & Programs

Risk Evaluation & Mitigation Strategies (REMS) Policy Summit

On Friday, May 7, 2010, NCCN held the NCCN Oncology Summit: Recommendations for REMS Stakeholders.  The NCCN Oncology Summit presented the recommendations of the NCCN Risk Evaluation and Mitigation Strategies (REMS) Work Group.  The NCCN Oncology Summit convened attendees from a broad array of organizations to discuss issues surrounding the development and implementation of REMS.  Members of the NCCN REMS Work Group presented real-world recommendations that aim to assure patient safety while balancing issues concerning barriers to medications and provider workload.  Along with presenting recommendations, the speakers highlighted the challenges stakeholders face when developing and implementing REMS.  Many key challenges were further illustrated by the opinions shared by the respondents of the March 2010 NCCN Trends™ Survey that focused on REMS.

To review the transcripts of the NCCN Oncology Summit, please click below:
Morning Session
Afternoon Session

To start, an introduction of REMS was given by Phil Johnson, RPh of H. Lee Moffitt Cancer Center & Research Institute.  In Part 1, Peyton Howell, MHA of AmerisourceBergen Specialty Group and Scott Gottlieb, MD of the American Enterprise Institute for Public Policy, presented the issues and recommendations developed by the NCCN REMS Work Group on the topics of Development of REMS, Standardization of REMS, Assessment of REMS, Medication Guides, and REMS and Off-label Indications.  Sharon Weinstein, MD of the Huntsman Cancer Institute at the University of Utah, and Shirley Johnson, RN, of the City of Hope Comprehensive Cancer Center presented Part 2 of the recommendations.  These recommendations were focused on Education of Providers, Prescribing and Prescribing Metrics, Compensation and Reimbursement, Patient Issues, and Implementation of REMS in Health Care Systems.

To review the slides presented at the NCCN Oncology Summit: Recommendations for REMS Stakeholders, click below:
Introduction of REMS
Part 1
Part 2


NCCN Content is a valuable asset of NCCN and is protected by copyright, trademark and other intellectual property rights owned by the NCCN. No portion of the NCCN Content may be copied, transferred, reproduced, modified or otherwise used for any purpose without the express written authorization of NCCN.

To request multiple copies of these slides or to use its content, please contact Marisa Getzewich, Business Development Coordinator.